Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015517
Filing Date
2021-11-10
Accepted
2021-11-10 16:32:53
Documents
55
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20210930x10q.htm   iXBRL 10-Q 1359203
2 EX-10.1 gbio-20210930xex10d1.htm EX-10.1 584567
3 EX-31.1 gbio-20210930xex31d1.htm EX-31.1 7417
4 EX-31.2 gbio-20210930xex31d2.htm EX-31.2 7556
5 EX-32.1 gbio-20210930xex32d1.htm EX-32.1 5123
6 EX-32.2 gbio-20210930xex32d2.htm EX-32.2 5102
  Complete submission text file 0001558370-21-015517.txt   5273271

Data Files

Seq Description Document Type Size
7 EX-101.SCH gbio-20210930.xsd EX-101.SCH 27625
8 EX-101.CAL gbio-20210930_cal.xml EX-101.CAL 43159
9 EX-101.DEF gbio-20210930_def.xml EX-101.DEF 102705
10 EX-101.LAB gbio-20210930_lab.xml EX-101.LAB 261178
11 EX-101.PRE gbio-20210930_pre.xml EX-101.PRE 224940
12 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20210930x10q_htm.xml XML 658824
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 211397210
SIC: 2834 Pharmaceutical Preparations